Inhibition of the rapid endocytotic uptake of Ahsg was demonstrated in TLR4-knockdown prostate tumor cells treated with a TLR4-specific inhibitor (CLI-095), which inhibited tumor cell adhesion and invasion through Matrigel [33]. Here, AHSG is linked to neoplasm.